Skip to main content
GRDX
NASDAQ Life Sciences

GridAI Technologies Receives Nasdaq Delisting Notice for Late 10-K Filing

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$2.24
Mkt Cap
$7.531M
52W Low
$1.65
52W High
$7.02
Market data snapshot near publication time

summarizeSummary

GridAI Technologies Corp. received a Nasdaq delisting notice for failing to file its 2025 annual 10-K report, citing complexities from a recent acquisition, and now has until June 22, 2026, to submit a compliance plan.


check_boxKey Events

  • Nasdaq Delisting Notice Received

    On April 22, 2026, GridAI Technologies Corp. received a letter from Nasdaq indicating non-compliance with Listing Rule 5250(c)(1) for failing to file its 10-K for the period ended December 31, 2025.

  • Compliance Deadline Set

    The company has 60 calendar days from April 22, 2026 (until June 22, 2026) to submit a plan to regain compliance. If accepted, Nasdaq may grant an extension up to 180 days, through October 12, 2026.

  • Reason for Filing Delay

    The delay in filing the Annual Report on Form 10-K is attributed to the complexity in reviewing accounting treatment and other information related to the company's recent acquisition of Grid AI Corp.

  • Press Release Issued

    On April 28, 2026, the company issued a press release announcing the receipt of the Nasdaq notice regarding the late 10-K filing.


auto_awesomeAnalysis

GridAI Technologies Corp. has received a formal notice from Nasdaq regarding its non-compliance with continued listing rules due to the failure to file its annual 10-K report. This is a critical event for the company, as it faces potential delisting if it cannot submit a compliance plan and subsequently file the overdue report within the stipulated deadlines. The delay is attributed to complexities arising from a recent acquisition, which introduces uncertainty regarding the company's financial reporting and operational stability. Investors should monitor the company's progress in regaining compliance, as failure to do so would severely impact its stock's liquidity and investor confidence.

At the time of this filing, GRDX was trading at $2.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $7.5M. The 52-week trading range was $1.65 to $7.02. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed GRDX - Latest Insights

GRDX
Apr 28, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
9
GRDX
Apr 13, 2026, 6:01 AM EDT
Filing Type: 8-K/A
Importance Score:
9
GRDX
Jan 07, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
9